SPAG17 Knockout HEK293 Cell Line
Cat.No.:
EDC08184
Species:
Human
Cell Name:
HEK293
Gene:
SPAG17
Gene ID:
200162
Size:
1×10⁶cells
SPAG17 Knockout Cell Line (HEK293) is an exclusive upgraded CRISPR/Cas9 system-mediated gene knockout cell, with the advantages of Optimized Strategy Design, Efficient Cell Transfection, High-Performance Cas9 Protein and Hassle-Free Cell Selection.
| Cat.No. | EDC08184 |
|---|---|
| Product Name | SPAG17 Knockout Cell Line (HEK293) |
| Cell Line | HEK293 |
| Cellosaurus ID | CVCL_0045 |
| Cell Line Synonyms | Hek293, HEK-293, HEK/293, (HEK)293, HEK 293, HEK,293, 293, 293 HEK, 293 Ad5, Graham 293, Graham-293, Human Embryonic Kidney 293 |
| Gene |
SPAG17 |
| NCBI Gene ID | |
| Gene Synonyms | CT143|PF6|SPGF55 |
| Summary |
This gene encodes a central pair protein present in the axonemes of cells with a "9 + 2" organization of microtubules. The encoded protein is required for the proper function of the axoneme. Mutations in the orthologous gene in mice lead to primary ciliary dyskinesia characterized by immotile nasal and tracheal cilia, reduced clearance of nasal mucus, profound respiratory distress, hydrocephalus, and neonatal lethality within twelve hours of birth due to impaired airway mucociliary clearance. Single-nucleotide polymorphisms in this gene are associated with human height and targeted mutations lead to skeletal malformations affecting the limbs in mice, suggesting a role for this gene in skeletal development. [provided by RefSeq, Feb 2017]
|
| Associated Diseases | Non-tumor |
| Morphology | Adherent |
| Passage Ratio | 1/5,2days |
| Complete Culture Medium | DMEM + 10% FBS |
| Freezing Medium | 95% Complete culture medium+ 5% DMSO |
| QC | Indels validated by Sanger sequencing; sterility confirmed via microbial testing. |
* For research use only. Not intended for use in humans or animals, including clinical, therapeutic, or diagnostic purposes.
| Loci | STR Info (Sample Cell) Sample Cell Line: HEK293 | STR Info (Cell bank) Cell Line: HEK293 | ||
| Allele1 | Allele2 | Allele1 | Allele2 | |
| Amelogenin | X | X | ||
| CSF1P0 | 12 | 11 | 12 | |
| D2S1338 | 19 | 19 | ||
| D3S1358 | 15 | 17 | 15 | 17 |
| D5S818 | 8 | 8 | 9 | |
| D7S820 | 11 | 12 | 11 | 12 |
| D8S1179 | 12 | 14 | 12 | 14 |
| D13S317 | 12 | 14 | 12 | 14 |
| D16S539 | 9 | 13 | 9 | 13 |
| D18S51 | 17 | 18 | 17 | 18 |
| D19S433 | 15 | 18 | 15 | 18 |
| D21S11 | 28 | 30.2 | 28 | 30.2 |
| FGA | 23 | 23 | ||
| Penta D | 9 | 10 | 9 | 10 |
| Penta E | 7 | 15 | 7 | 15 |
| TH01 | 7 | 9.3 | 7 | 9.3 |
| TPOX | 11 | 11 | ||
| vWA | 16 | 19 | 16 | 19 |
| D6S1043 | 11 | 11 | ||
| D12S391 | 19 | 21 | 11 | 15 |
| D2S441 | 11 | 15 | 11 | 15 |
* STR authentication data of this cell line matches with that of cell lines sourced from ATCC, DSMZ, JCRB, and RIKEN databases.
Conclusion: The STR identification of this cell is correct.
Conclusion: The STR identification of this cell is correct.
FAQ
Which is better for studying SPAG17 function, SPAG17 Knockout HEK293 Cell Line or SPAG17 overexpression HEK293 Cell Line?
The choice depends on the experimental question. SPAG17 is normally expressed in cilia and flagella, particularly in respiratory epithelium and sperm — HEK293 expresses minimal endogenous SPAG17. The Knockout line in HEK293 is most useful for biochemical and interactome studies in a clean background, since HEK293 is not the physiologically relevant cell type for SPAG17 function. Overexpression in HEK293 may be more informative for structural and biochemical characterization of SPAG17.
For SPAG17 research focused on physiological function — primary ciliary dyskinesia modeling, sperm motility studies, bone biology (SPAG17 has emerging roles in osteoblast function) — ciliated cell models or primary cells are more appropriate than HEK293. The EDITGENE Knockout in HEK293 is useful for confirming complete loss in cells with low baseline expression and for heterologous expression studies. Rescue with wild-type or epitope-tagged SPAG17 enables initial interactome characterization.
What are the application scenarios for this model?
Primary applications:
• Heterologous expression studies: interactome characterization of exogenously expressed SPAG17 in the clean knockout background using co-immunoprecipitation and mass spectrometry.
• Domain mapping: biochemical characterization of SPAG17's multiple structural domains using truncation constructs.
• Discovery transcriptomics: RNA-seq in the knockout to identify gene expression changes associated with SPAG17 loss in a heterologous context.
• Antibody validation: clean negative control for anti-SPAG17 antibody specificity testing.
EDITGENE recommends this model for researchers requiring heterologous SPAG17 expression in a clean genetic background. Physiologically relevant SPAG17 research (primary ciliary dyskinesia, sperm motility) requires ciliated or sperm-derived models.
Is this SPAG17 Knockout HEK293 Cell Line compatible with overexpression rescue experiments?
Yes, with important context considerations:
• Construct design: SPAG17 is large (~2,223 amino acids); use codon-modified sequences with C-terminal tags (FLAG, HA). Full-length cloning requires careful vector selection.
• Heterologous expression context: HEK293 does not normally express SPAG17 at functional levels — rescue is effectively a controlled heterologous expression study. Physiological SPAG17 function in cilia requires ciliated cell models.
• Truncation rescue: given SPAG17's size, truncation constructs covering specific domains may be more tractable for biochemical and interactome studies than full-length rescue.
• Functional readout: rescue should restore phenotypes identified in discovery transcriptomics or interactome studies; ciliary function readouts are not applicable in HEK293.
HEK293 transduces efficiently with lentivirus, though large cargo size may reduce titer; consider multi-vector strategies for full-length SPAG17 delivery.
* Research Use Disclaimer: Content is generated from publicly available research data, bioinformatic resources, and computational analyses for research reference only.